Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells
- PMID: 24989059
- PMCID: PMC4094603
- DOI: 10.1186/1471-2180-14-177
Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells
Abstract
Background: Clostridium difficile is the main cause of hospital-acquired diarrhea and colitis known as C. difficile-associated disease (CDAD).With increased severity and failure of treatment in CDAD, new approaches for prevention and treatment, such as the use of probiotics, are needed. Since the pathogenesis of CDAD involves an inflammatory response with a massive influx of neutrophils recruited by interleukin (IL)-8, this study aimed to investigate the probiotic effects of Lactobacillus spp. on the suppression of IL-8 production in response to C. difficile infection.
Results: We screened Lactobacillus conditioned media from 34 infant fecal isolates for the ability to suppress C. difficile-induced IL-8 production from HT-29 cells. Factors produced by two vancomycin-resistant lactobacilli, L. rhamnosus L34 (LR-L34) and L.casei L39 (LC-L39), suppressed the secretion and transcription of IL-8 without inhibiting C. difficile viability or toxin production. Conditioned media from LR-L34 suppressed the activation of phospho-NF-κB with no effect on phospho-c-Jun. However, LC-L39 conditioned media suppressed the activation of both phospho-NF-κB and phospho-c-Jun. Conditioned media from LR-L34 and LC-L39 also decreased the production of C. difficile-induced GM-CSF in HT-29 cells. Immunomodulatory factors present in the conditioned media of both LR-L34 and LC-L39 are heat-stable up to 100°C and > 100 kDa in size.
Conclusions: Our results suggest that L. rhamnosus L34 and L. casei L39 each produce factors capable of modulating inflammation stimulated by C. difficile. These vancomycin-resistant Lactobacillus strains are potential probiotics for treating or preventing CDAD.
Figures




Similar articles
-
The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.Probiotics Antimicrob Proteins. 2021 Aug;13(4):949-956. doi: 10.1007/s12602-020-09729-5. Epub 2021 Jan 25. Probiotics Antimicrob Proteins. 2021. PMID: 33492661
-
Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells.BMC Microbiol. 2016 Oct 18;16(1):242. doi: 10.1186/s12866-016-0861-x. BMC Microbiol. 2016. PMID: 27756217 Free PMC article.
-
Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface.Arch Oral Biol. 2017 Apr;76:1-6. doi: 10.1016/j.archoralbio.2016.12.014. Epub 2016 Dec 31. Arch Oral Biol. 2017. PMID: 28063305
-
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.Clin Infect Dis. 2015 May 15;60 Suppl 2:S135-43. doi: 10.1093/cid/civ179. Clin Infect Dis. 2015. PMID: 25922399 Review.
-
Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.J Hosp Infect. 2018 Aug;99(4):443-452. doi: 10.1016/j.jhin.2018.04.017. Epub 2018 Apr 24. J Hosp Infect. 2018. PMID: 29702133 Review.
Cited by
-
Candida Administration Worsens Cecal Ligation and Puncture-Induced Sepsis in Obese Mice Through Gut Dysbiosis Enhanced Systemic Inflammation, Impact of Pathogen-Associated Molecules From Gut Translocation and Saturated Fatty Acid.Front Immunol. 2020 Sep 25;11:561652. doi: 10.3389/fimmu.2020.561652. eCollection 2020. Front Immunol. 2020. PMID: 33101279 Free PMC article.
-
Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.Infect Immun. 2017 Sep 20;85(10):e00303-17. doi: 10.1128/IAI.00303-17. Print 2017 Oct. Infect Immun. 2017. PMID: 28760934 Free PMC article.
-
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.Front Microbiol. 2016 Apr 22;7:577. doi: 10.3389/fmicb.2016.00577. eCollection 2016. Front Microbiol. 2016. PMID: 27148250 Free PMC article.
-
Probiotics for Prevention and Treatment of Clostridium difficile Infection.Adv Exp Med Biol. 2024;1435:101-116. doi: 10.1007/978-3-031-42108-2_6. Adv Exp Med Biol. 2024. PMID: 38175473
-
Core Fucosylation of Maternal Milk N-Glycan Evokes B Cell Activation by Selectively Promoting the l-Fucose Metabolism of Gut Bifidobacterium spp. and Lactobacillus spp.mBio. 2019 Apr 2;10(2):e00128-19. doi: 10.1128/mBio.00128-19. mBio. 2019. PMID: 30940702 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous